Innovent Biologics

Compliant

Under AAOIFI Standard 21, Innovent Biologics is compliant. Its core business is permissible and its interest-bearing debt is below 30% of market cap.

Ticker1801

ExchangeHKEX

SectorBiopharmaceuticals

Full ratios for Innovent Biologics (impure revenue, debt and interest-bearing deposits under all four standards) are being added. Until then this page shows the screening verdict only. See the methodology for how each test works. Purindex publishes this screening to help people understand what they own. It does not recommend buying, selling or holding Innovent Biologics or any other security.